DUBLIN--(BUSINESS WIRE)--The "Protein Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global protein therapeutics market to grow with a CAGR of 9.4% over the forecast period of 2018-2024.
The report on global protein therapeutics market provides qualitative and quantitative analysis for the period of 2016 to 2024.
The report on protein therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global protein therapeutics market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global protein therapeutics market over the period of 2016 to 2024. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
The global protein therapeutics market is segmented on the basis of protein function and product type.
Global Protein Therapeutics Market by Protein Function
- Enzymatic And Regulatory
- Protein Diagnostics
Global Protein Therapeutics Market by Product Type
- Monoclonal Antibodies
- Follicle Stimulating Hormone
- Blood Clotting Factor
- Baxter International
- F. Hoffmann-La Roche
- Eli Lilly
- Generex Biotechnology
- Novo Nordisk
- Johnson & Johnson
For more information about this report visit https://www.researchandmarkets.com/research/jmm8r4/global_protein?w=4